Valsartan Intensified Primary Care Reduction of Blood Pressure Study
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy of an intensive blood pressure management strategy
compared to usual care in a primary care (general practice) setting.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis Pharmaceuticals
Collaborators:
Baker Heart and Diabetes Institute Baker IDI Heart and Diabetes Institute
Treatments:
Amlodipine Amlodipine, Valsartan Drug Combination Hydrochlorothiazide Valsartan